Reference
Masuda T, et al. A patient with KL-6 elevation with anti-TNFalpha who could receive long-term use without interstitial pneumonia after class switch of Anti-TNFalpha. Inflammatory Intestinal Diseases 4: 35-40, No. 1, May 2019. Available from: URL: http://doi.org/10.1159/000497778 - Japan
Rights and permissions
About this article
Cite this article
Adalimumab/infliximab. Reactions Weekly 1757, 21 (2019). https://doi.org/10.1007/s40278-019-63249-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-63249-z